Identification of a Transactivation Function in the Progesterone Receptor That Interacts with the TAFII110 Subunit of the TFIID Complex (*)

Transcriptional activation of target genes by the human progesterone receptor is thought to involve direct or indirect protein-protein interactions between the progesterone receptor and general transcription factors. A key role in transcription plays the general transcription factor TFIID, a multiprotein complex consisting of the TATA-binding protein and several tightly associated factors (TAFs). TAFs have been shown to be required for activated transcription and are, thus, potential targets of activator proteins. Using in vitro interaction assays, we could identify specific interactions between the progesterone receptor and the TATA-binding protein-associated factor dTAFII110. The dTAFII110 domain responsible for the interaction is distinct from that reported to suffice for binding to Sp1. Somewhat surprisingly, deletion analysis indicated that the previously identified activation functions 1 and 2 of the progesterone receptor are not required for this interaction but pointed to an important role of the DNA binding domain. In cotransfection experiments and an in vitro transcription assay, the DNA binding domain of the progesterone receptor displayed significant activation potential. These findings, taken together, suggest that an interaction between the progesterone receptor and TAFII110 may represent an important step in the mechanism of activation.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  G. Ryffel,et al.  Developmental expression of the maternal protein XDCoH, the dimerization cofactor of the homeoprotein LFB1 (HNF1). , 1995, Development.

[3]  R. Roeder,et al.  Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators , 1995, Science.

[4]  R. Tjian,et al.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.

[5]  E. Kieff,et al.  The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein , 1995, Journal of virology.

[6]  K. Dahlman-Wright,et al.  The glucocorticoid receptor functions at multiple steps during transcription initiation by RNA polymerase II. , 1994, The Journal of biological chemistry.

[7]  R. Tjian,et al.  Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators , 1994, Cell.

[8]  X. Jacq,et al.  Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor , 1994, Cell.

[9]  Tom Maniatis,et al.  Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.

[10]  Richard A. Young,et al.  An RNA polymerase II holoenzyme responsive to activators , 1994, Nature.

[11]  M. Montminy,et al.  The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Wootton,et al.  Molecular cloning of Drosophila TFIID subunits , 1994, Nature.

[13]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Tjian,et al.  Molecular cloning and characterization of dTAFII30 alpha and dTAFII30 beta: two small subunits of Drosophila TFIID. , 1993, Genes & development.

[15]  M. Horikoshi,et al.  Molecular cloning, expression, and characterization of the Drosophila 85-kilodalton TFIID subunit , 1993, Molecular and cellular biology.

[16]  R. Tjian,et al.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.

[17]  D. Reinberg,et al.  Isolation of a cDNA encoding the largest subunit of TFIIA reveals functions important for activated transcription. , 1993, Genes & development.

[18]  R. Roeder,et al.  A single cDNA, hTFIIA/alpha, encodes both the p35 and p19 subunits of human TFIIA. , 1993, Genes & development.

[19]  G. Ryffel,et al.  Elements and factors involved in tissue-specific and embryonic expression of the liver transcription factor LFB1 in Xenopus laevis , 1993, Molecular and cellular biology.

[20]  M. Horikoshi,et al.  The Drosophila 110-kDa transcription factor TFIID subunit directly interacts with the N-terminal region of the 230-kDa subunit. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Tjian,et al.  Largest subunit of Drosophila transcription factor IID directs assembly of a complex containing TBP and a coactivator , 1993, Nature.

[22]  P. Chambon,et al.  Defining a minimal estrogen receptor DNA binding domain. , 1993, Nucleic acids research.

[23]  R. Tjian,et al.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.

[24]  Qiang Zhou,et al.  Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. , 1992, Genes & development.

[25]  B. O’Malley,et al.  Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). , 1992, The Journal of biological chemistry.

[26]  W. Herr,et al.  Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Reinberg,et al.  Advances in RNA polymerase II transcription , 1992, Current Biology.

[28]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[29]  A. Nardulli,et al.  Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells. , 1991, The Journal of biological chemistry.

[30]  R. Tjian,et al.  Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. , 1991, Genes & development.

[31]  R. Tjian,et al.  Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation , 1991, Cell.

[32]  G. Ryffel,et al.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. , 1991, Nucleic acids research.

[33]  P. Chambon,et al.  Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. , 1990, The EMBO journal.

[34]  P. Lieberman,et al.  Cloning of a transcriptionally active human TATA binding factor. , 1990, Science.

[35]  R. Tjian,et al.  Functional domains and upstream activation properties of cloned human TATA binding protein. , 1990, Science.

[36]  B. Lewin.  Commitment and activation at pol II promoters: A tail of protein-protein interactions , 1990, Cell.

[37]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[38]  B. O’Malley,et al.  The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex , 1990, Cell.

[39]  P. Chambon,et al.  The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. , 1989, Nucleic acids research.

[40]  P. Sharp,et al.  Five intermediate complexes in transcription initiation by RNA polymerase II , 1989, Cell.

[41]  G. Ryffel,et al.  A cell‐specific activator in the Xenopus A2 vitellogenin gene: promoter elements functioning with rat liver nuclear extracts. , 1988, The EMBO journal.

[42]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[43]  S. Green,et al.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering , 1988, Nucleic Acids Res..

[44]  K. Yamamoto,et al.  Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. , 1987, Science.

[45]  R. Evans,et al.  Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor , 1987, Cell.

[46]  Pierre Chambon,et al.  Carcinogenesis: A superfamily of potentially oncogenic hormone receptors , 1986, Nature.

[47]  Gerhart U. Ryffel,et al.  An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells , 1986, Cell.

[48]  R. Roeder,et al.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[50]  H. Gronemeyer,et al.  Transcription activation by estrogen and progesterone receptors. , 1991, Annual review of genetics.